Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients 2025-04-11 13:19
Florida Theranostics Brings Cutting-Edge United Imaging Digital PET/CT to Palm Beach County, Florida 2025-04-11 00:27
Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week 2025-04-10 21:37
Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer 2025-04-10 20:00
Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models 2025-04-10 11:07
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer 2025-04-10 10:00
Ractigen's RAG-17 ALS Data Shines at AAN 2025: Earns Top Award, Phase I Advances 2025-04-09 20:00
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology 2025-04-09 19:54
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine 2025-04-09 12:00
VARON Expands Access to Oxygen Therapy--Breathing Easier, Living Stronger 2025-04-09 08:18
Medit Reaffirms Commitment to American Dental Providers: No Price Increases for U.S. Customers 2025-04-09 00:00
MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025 2025-04-08 15:38
Duality Bio Appoints Hua Mu as Global Chief Medical Officer 2025-04-07 12:52
Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder 2025-04-07 08:00
The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine 2025-04-06 10:12
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split 2025-04-05 04:05
Ex-FDA Expert Dr. Yaning Wang Joins Tsingke to Drive Small Nucleic Acid Drug Innovation 2025-04-04 20:58
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies 2025-04-03 19:30
Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record Growth 2025-04-03 15:25
Mabwell Announces NMPA Approval to Initiate Clinical Trial of novel B7-H3-targeting ADC for Advanced Solid Tumors in Combination with PD-1 Inhibitor 2025-04-02 22:00